SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-09-011494
Filing Date
2009-03-02
Accepted
2009-03-02 08:20:54
Documents
2
Period of Report
2009-02-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.04: Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT v141622_8k.htm 8-K 58615
2 FORM OF SEPARATE FORBEARANCE AND AMENDMENT AGREEMENT v141622_ex10-1.htm EX-10.1 110068
  Complete submission text file 0001144204-09-011494.txt   170390
Mailing Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CA A1 M5J 2G2
Business Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CANA A1 M5J 2G2 4163642551
GENEREX BIOTECHNOLOGY CORP (Filer) CIK: 0001059784 (see all company filings)

IRS No.: 820490211 | State of Incorp.: DE | Fiscal Year End: 0731
Type: 8-K | Act: 34 | File No.: 000-25169 | Film No.: 09645424
SIC: 2834 Pharmaceutical Preparations